AVENIO Tumor Tissue CGP Kit V2

For Research Use Only. Not for use in diagnostic procedures. Others AVENIO Tumor Tissue CGP Kit V2 RUO AVENIO Tumor Tissue CGP Kit V2 PID00000815 10 240 814 001 10240814001 AVENIO Tumor Tissue CGP Kit A V2 AVENIO Tumor Tissue CGP Kit A V2 07613336230862 Other Services Plate A: 24 reactions Not Available true 10 240 822 001 10240822001 AVENIO Tumor Tissue CGP Kit B V2 AVENIO Tumor Tissue CGP Kit B V2 07613336230879 Other Services Plate B: 24 reactions Not Available true The AVENIO Tumor Tissue CGP Kit V2 includes the reagents needed to isolate DNA from FFPE tissue, prepare sequencing libraries, and enrich selected regions of interest using the AVENIO Tumor Tissue CGP Panel V2. It also includes a cloud-based secondary data analysis softw are called the FoundationOne® Analysis Platform as well as a data management software called AVENIO Connect. This ready-to-use kit uses a hybrid-capture based workflow for molecular profiling of DNA derived from FFPE solid tumor tissue. The AVENIO Tumor Tissue CGP Kit V2 helps labs consistently purify and enrich targeted regions in DNA from FFPE solid tumor tissue for sequencing. It provides lab professionals the ability to generate meaningful genomics insights from all classes of genomic alterations - Single-Nucleotide Variants, Insertions and Deletions, Copy Number Alterations, and Rearrangements - as well as relevant genomic signatures such as Tumor Mutational Burden, Microsatellite Instability, genomic Loss of Heterozygosity and Homologous Recombination Deficiency signature, using a DNA workflow. Each kit includes reagents for processing up to 24 reactions pooled into two to three sequencing runs of up to 8-12 libraries on an Illumina® NextSeq 500/550 or Illumina NextSeq 550 Dx in RUO Mode. en